Phil Nalbone
Director at Reprise Biomedical.
- Plymouth, MN
- Reprise Biomedical
Raised on Reprise Biomedical filings
$9.2M
of $10M offered across 2 Form D filings
- Form D filings
- 2
- Teammates
- 12
- Last filing
- Jul 1, 2026
Company
Pig liver collagen scaffolds for deep wounds
- Investors
- 4
- Still open
- $754K
Reprise Biomedical filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Jul 1, 2026 | Equity | $9.2M/ $10M | Form D/A |
| May 21, 2026 | Equity | $1.4M/ $8M | Form D |
Works with
Carrie PowersChief Executive Officer, Form D signerForm D signerJeff DuncanExecutive OfficerAlan WoldtDirectorErwin KelenDirectorGreg SmockExecutive OfficerHeather KotilaExecutive OfficerHoward RootDirectorJake IsenburgExecutive OfficerJerrod KruegerExecutive OfficerRonald EibensteinerDirectorSteve JagodzinskiExecutive OfficerTom KouchoukosExecutive Officer
